It’s frustrating when the reverse split isn’t properly taken into account. But that company’s journey is still not amounting to anything.
1 Like
So is this company the pharmaceutical industry’s own Summa Defence from Sweden?
The name is an omen - pronounced “ex-brain” - this is where those who once had brains invest. Including, unfortunately, me.